Absent T Lymphocytes

Search Trials
Second-line Therapy of Unresectable Cholangiocarcinoma by RADIOEMBOLIZATION
Status:
Terminated
Last Changed:
Aug 7, 2013
First Changed:
Jun 28, 2011
Disease(s):
Cholestasis, Progressive Familial Intrahepatic 3
Intervention(s):
Yttrium microsphere injection
Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders
Status:
Completed
Last Changed:
Nov 13, 2019
First Changed:
Mar 5, 2009
Disease(s):
Accelerated Phase Chronic Myelogenous Leukemia
Intervention(s):
fludarabine phosphatemelphalantotal-body irradiationallogeneic hematopoietic stem cell transplantationanti-thymocyte globulin
Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications
Status:
Completed
Last Changed:
Mar 7, 2012
First Changed:
Nov 27, 2008
Disease(s):
Accelerated Phase Chronic Myelogenous Leukemia
Intervention(s):
internet-based interventionquestionnaire administrationpsychosocial assessment and careassessment of therapy complicationsmanagement of therapy complicationsfatigue assessment and managementcounseling intervention
Study of Bortezomib and Panobinostat in Treating Patients With Relapsed/Refractory Peripheral T-cell Lymphoma or NK/T-cell Lymphoma
Status:
Completed
Last Changed:
Jun 27, 2014
First Changed:
May 13, 2009
Disease(s):
Peripheral T-cell Lymphoma (Not Otherwise Specified)
Intervention(s):
panobinostat and bortezomib
Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma
Status:
Active, not recruiting
Last Changed:
Aug 12, 2021
First Changed:
Apr 13, 2017
Disease(s):
Adult T-Cell Leukemia/Lymphoma
Intervention(s):
Brentuximab VedotinCyclophosphamideDoxorubicinEtoposideLaboratory Biomarker AnalysisPrednisone

Connect. Empower. Inspire.